Key facts
- Notable investors include Beijing Delian Yuntong Investment Management Company, Hongshen Asset.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Link Medical (Enterprise Systems (Healthcare))
- ·The full record, as it builds
Funding rounds
No funding rounds for Link Medical (Enterprise Systems (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Link Medical (Enterprise Systems (Healthcare))
Developer of treatment techniques intended to serve medical doctors and patients. The company is mainly focused on the research and development of the intelligent temperature control treatment technology used in the equipment focused on treatment areas such as stroke, brain trauma, myocardial infarction, cardiac arrest, and kidney transplantation, providing clients with industry-leading standard products.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2022
- Employees
- 20
- Website
- lkmed.com.cn/
- Ownership
- Privately Held (backing)
Link Medical (Enterprise Systems (Healthcare)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Link Medical (Enterprise Systems (Healthcare)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Link Medical (Enterprise Systems (Healthcare)) in its N-PORT filings yet. We sweep new filings monthly.